AKNA directly binds the A/T-rich promoters regions of CD40 and CD40 ligand (CD40L) and coordinately regulates their expression, thereby activate antitumor immune response, while HPV E6, a cervical cancer-related oncoprotein, could downregulate AKNA and lead to the progression of cancer [6, 7]. Here, CD40LG is linked to cervical cancer.